Multiple myeloma blood disease classification

Blood type disease According to the international law Diseases (ICD) named blood disease diseases. Patients will be divided into red cell blood disease, leukocyte disease and hemorrhagic disease three categories 1. Red blood cell disease: iron deficiency anemia, nutritional megaloblastic anemia, 6 - G6PDH lack of hemolytic anemia, autoimmune hemolytic anemia, thalassemia, aplastic anemia and paroxysmal nocturnal Hemoglobinuria, blood loss anemia, Erythrocytosis.
Second, interleukin disease: leukopenia, myelodysplastic syndrome, leukemia, lymphoma, infectious mononucleosis disease, infectious disease increased lymphocytes, eosinophils increased disease, multiple myeloma, malignant cells disease, hypersplenism disease, myelofibrosis.
C, hemorrhagic disease: Henoch - Schonlein purpura, primary thrombocytopenic purpura, primary thrombocythemia disease, hemophilia, the inherited platelet unable disease, disseminated intravascular coagulation of the blood types: aplastic anemia hemolytic anemia myelodysplastic syndrome of acute leukemia chronic leukemia lymphoma multiple myeloma myelofibrosis anaphylactoid purpura idiopathic thrombocytopenic purpura myelodysplastic syndrome referred to as "MDS" is a group of multi-origin functional hematopoietic stem cell clonal proliferation of bone marrow disease. Formerly known as "pre - leukemia", but found the disease by clinical observation does not necessarily have to develop into leukemia, the disease has increased in recent years the trend of the past that the disease occurs in more than 50-year-old middle-aged and elderly, in recent years found young people do not rare cases. Most of the clinical performance of whole-cell reduction, increased proliferation of bone marrow hematopoietic cells with pathological blood. Most scholars believe that the causes of morbidity due to chemical drugs, chemicals and radioactive substances caused abnormal hematopoietic stem cell proliferation, differentiation and disease. The disease is divided into refractory anemia (RA), refractory anemia with iron tablets David Ring cells increased (RAS), refractory anemia with primitive cells increased (RAEB), changes in refractory anemia with the original hard cells increased (RAEB-t), chronic granulocytic leukemia mononuclear cells (CMML) five types (WHO would chronic granulocytic leukemia classified mononuclear cells to the bone marrow proliferative diseases, changes in refractory anemia with primitive cells increased classified into acute leukemia). Its main clinical manifestations to anemia, the most symptomatic patients often complained began to fatigue, weakness, shortness of breath and looking pale, pale lips and nail, and even dizziness, lightheadedness, heart palpitations, fever, nasal cavity, bleeding gums, about 20% of the patients Splenomegaly but half of asymptomatic patients in medical or accidental discovery. Laboratory examination, blood examination showed anemia, red blood cells, hemoglobin decreased to 90 per cent, half of patients with erythrocyte, leukocyte and platelet reduced, a small number of simple thrombocytopenia, and see tremendous RBC and platelet huge, nucleated red blood cells, and other pathological hematopoietic